Many people enjoy a drink during the Christmas period, but lots of people also need to travel over the holidays - here's how ...

FORGET decorating the Christmas tree and wrapping presents, this year there’s a new festive stress to contend with… for the ...

On today's Morning Brief, Yahoo Finance executive editor Brian Sozzi helps investors start their trading day off right by covering the top market headlines before the opening bell on December 23, 2025 ...

IAEA assists countries in minimising unnecessary radiation exposure while ensuring treatments deliver required dose.

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.

NOTE: Images in exported zip file from Google Docs may not appear in the same order as they do in your doc. Please check the ...

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...

A triple dose of Novo Nordisk's GLP-1 agonist Wegovy has shown improved activity on weight loss in an obesity trial, as the drugmaker tries to fend off a marketplace challenge from Eli Lilly. A 7.2mg ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent ...

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.